Publications by authors named "Jill Slansky"

Claim this Profile
V
Vector-free DNA transfection by nuclear envelope mechanoporation.
Leyla Akh, Apresio K Fajrial, Benjamin Seelbinder, Xin Xu, Wei Tan, Jill Slansky

ArXiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells.
Lindsey A Murphy, Laura Sedivy, M Eric Kohler, Kimberly R Jordan, Angela Ohm, Jill E Slansky

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer.
Alan M Elder, Heather R Fairchild, Kelsey T Kines, Lauren M Cozzens, Alexandria R Becks, Jill E Slansky

Cell Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.
Anthony D Elias, Alyse W Staley, Monica Fornier, Gregory A Vidal, Vida Alami, Jill E Slansky

NPJ Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity.
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Jill E Slansky

J Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating Lymphocytes.
Zachary L Z Hay, Jennifer R Knapp, Roman E Magallon, Brian P O'Connor, Jill E Slansky

Cancer Immunol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 T Cell Immunity.
Faye A Camp, Tonya M Brunetti, Michelle M Williams, Jessica L Christenson, Varsha Sreekanth, Jill E Slansky

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response.
Yang Wang, Alexandra Tsitsiklis, Stephanie Devoe, Wei Gao, H Hamlet Chu, Jill E Slansky

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.
Zachary L Z Hay, Jill E Slansky

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Antigen Selection on T Cell-Based Immunotherapy.
Faye A Camp, Jill E Slansky

Pharmaceuticals (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
Juan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, Stacey M Bagby, Sarah J Hartman, Jill E Slansky

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.
Pengcheng Wei, Kimberly R Jordan, Jonathan D Buhrman, Jun Lei, Hexiang Deng, Jill E Slansky

Proc Natl Acad Sci U S A· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.
Apresio K Fajrial, Qing Qing He, Nurul I Wirusanti, Jill E Slansky, Xiaoyun Ding

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer.
Michelle M Williams, Jessica L Christenson, Kathleen I O'Neill, Sabrina A Hafeez, Claire L Ihle, Jill E Slansky

NPJ Breast Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval.
Kimberly R Jordan, Matthew J Sikora, Jill E Slansky, Angela Minic, Jennifer K Richer

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery.
Steven C Katz, Ashley E Moody, Prajna Guha, John C Hardaway, Ethan Prince, Jill E Slansky

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell receptor affinity in the age of cancer immunotherapy.
Michele M Hoffmann, Jill E Slansky

Mol Carcinog· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide mimotopes alter T cell function in cancer and autoimmunity.
Jill E Slansky, Maki Nakayama

Semin Immunol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8 T-cell responses by upregulating MHC-I expression.
Joseph A Westrich, Daniel W Vermeer, Alexa Silva, Stephanie Bonney, Jennifer N Berger, Jill E Slansky

Oncogene· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression.
Jennifer L Rabe, Lori Gardner, Rae Hunter, Jairo A Fonseca, Jodi Dougan, Jill E Slansky

Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Splicing in Tumors - A Path to Immunogenicity?
Jill E Slansky, Paul T Spellman

N Engl J Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.
Lisa I Greene, Tullia C Bruno, Jessica L Christenson, Angelo D'Alessandro, Rachel Culp-Hill, Jill E Slansky

Mol Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.
Rebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, Rani K Powers, Jared Klarquist, Jill E Slansky

J Clin Invest· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.
Dmitri V Rozanov, Nikita D Rozanov, Kami E Chiotti, Ashok Reddy, Phillip A Wilmarth, Jill E Slansky

J Proteomics· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-Presenting Intratumoral B Cells Affect CD4 TIL Phenotypes in Non-Small Cell Lung Cancer Patients.
Tullia C Bruno, Peggy J Ebner, Brandon L Moore, Olivia G Squalls, Katherine A Waugh, Jill E Slansky

Cancer Immunol Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis